ImmunoglobuliN in the Treatment of Encephalitis (IgNiTE): protocol for a multicentre randomised controlled trial.
INTRODUCTION: Infectious and immune-mediated encephalitides are important but under-recognised causes of morbidity and mortality in childhood, with a 7% death rate and up to 50% morbidity after prolonged follow-up. There is a theoretical basis for ameliorating the immune response with intravenous immunoglobulin (IVIG), which is supported by empirical evidence of a beneficial response following its use in the treatment of viral and autoimmune encephalitis. In immune-mediated encephalitis, IVIG...Expand abstract
- Publication status:
- Peer review status:
- Peer reviewed
(Version of record, pdf, 1.3MB)
- Publisher copy:
- Copyright holder:
- Iro et al
- Copyright date:
- Author(s) retain copyright; published by BMJ Publishing Group under license. This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license.
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record